Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan drops $958M on migraine drug maker MAP Pharma
Allergan drops $958M on migraine drug maker MAP Pharma
Allergan drops $958M on migraine drug maker MAP Pharma
Submitted by
moderatorj
on January 23, 2013 - 9:24pm
Source:
Mass Device
News Tags:
Allergan
M&A
migraine
Headline:
Allergan drops $958M on migraine drug maker MAP Pharma
Do Not Allow Advertisers to Use My Personal information